Clinical Trial: SIB Accelerated Hyperfractionated RT for High-Proliferation NSCLC

U.S., Sept. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07823855) titled 'SIB Accelerated Hyperfractionated RT for High-Proliferation NSCLC' on Aug. 04.

Brief Summary: This is a prospective, single-arm, single-center phase I/II clinical trial evaluating the safety, objective response rate (ORR), progression-free survival (PFS), and overall survival (OS) of simultaneous integrated boost accelerated hyperfractionated radiotherapy in patients with high-proliferation non-small cell lung cancer (NSCLC).

Study Start Date: June 16

Study Type: INTERVENTIONAL

Condition: Non-Small Cell Lung Cancer

Intervention: RADIATION: hyperfractionated radiotherapy

simultaneous integrated boost accelerated hyperfraction...